Curriculum Vitae
 
 
Name:  Prof. Shiu Cho Tak Wesely
 
 
Address: Hong Kong Cancer Prevention and Treatment Center
          506, 5/F,
Yip Fung Building,
          2 D’aguilar Street,
          Central,
       Hong Kong.
 
 
Tel no.:                (852) 2586 1726
 
Home Tel no.:      (852) 2526 5141
 
Mobile phone:     (852) 9466 3019
 
Fax no.:               (852) 2596 0802
 
Email:          wesely@netvigator.com
 
 
 
 
MB. ChB. Manchester University
MRCP (U.K.)
MRCP (Ireland)
M.D. Manchester University
FRCP (Edinburgh)
Member of the American Society of Clinical Oncology
Fellow of H.K. Academy of Medicine (Medicine)
Fellow of H.K. College of Physician
Chairman of the Department of Clinical Oncology, Chinese University of Hong Kong (1982 – 1992)
Hon. Consultant in Oncology Prince of Wales Hospital (1987 – 1992)
Hon. Consultant in Oncology United Christian Hospital (1989 – 1992)
Hon. Professor in Oncology Shanghai Medical University China
Specialist in Medical Oncology (HK Academy of Medicine)
Director of Hong Kong Cancer Prevention and Treatment Center
Hon. Consultant in Oncology HK Baptist Hospital
 
曼徹斯特大學內外全科醫學士
英國皇家內科醫學院院士
愛爾蘭皇家內科醫學院院士
曼徹斯特大學醫學博士
英國愛丁堡皇家內科醫學院榮授院士
美國臨床腫瘤學會院士
香港醫學專科學院院士(內科)
香港內科學院院士
香港中文大學臨床腫瘤學系系主任(1987-1992)
沙田威爾斯親皇醫院腫瘤科顧問醫生(1987-1992)
九龍聯合醫院腫瘤科顧問醫生(1989-1992)
上海醫科大學腫瘤系榮譽教授
 
 
 
Previous Appointment: Chairman of the Department of Clinical Oncology
                               The Chinese University of Hong Kong (1987 – 1992)
 
University Degree: BSc St Andrew University
                         M.B.ChB. Manchester University
                         Distinction in Medicine
                            M.D. Manchester University
                            Title of Thesis: Migration of Lymphocytes in Health and Disease
 
Postgraduate Diploma: MR.C.P. (U.K.) 1981
                               MR.C.R. (Ireland) 1981
                               F.R.C.R. (Edin) 1990
                               FH.KA.M. (Medicine) 1993
                              Specialist in Medical Oncology
 
Honorary Appointment:
 
Director of Hong Kong Cancer Prevention and Treatment Centre
Consultant in Oncology Hong Kong Baptist Hospital
Visiting Professor of Soo-chow Medical School, China
Visiting Professor of Shanghai Medical University, China
 
Society:
 
Founding member of the Asian Oceanic Clinical Oncology Association
Founder of the Hong Kong Cancer Chemotherapy Society
Member of the American Society of Clinical Oncology
 
 
 
Publication List
 
Kelly W., Laing I., Walton L., Adam. J., Shiu W., Roberts C., Longson D., Davies D.
The response of patients with Nelson’s Syndrome to sodium valproate.
Br. J. of Clinical Practice (Symp.series) 1983, 27, 150-154.
 
Wagstaff J., Anderson H., Shiu W., Thatcher N.
Phase II study of Vindesine infusion in visceral metastaic malignant melanoma.
Cancer treatment reports 1983, 69(9), 839-840.
 
Steward W., Edmundson J., Shiu W., Thatcher N., Wilkinson P.M.
Etoposide infusion for the treatment of metastatic lung cancer.
Cancer treatment report 1984, 68:897-899
 
Shiu W., Wong F., Martin C.
Oncology Day Ward: An evaluation.
Singapore Medical J. 1987, 28, 190-192.
 
Wong F., O. S., Shiu W.
Pregnancy outcome following radiotherapy for NPC.
European J. of Obst.&Gynae.&Reproductive Biology, 1986, 22, 159-160.
 
Shiu W., Mok S.D., O. S., Tsao S.Y., Woo K., Li A., Leung N., Martin C.
Phase II trial of 4, epidoxorubicion in hepatoma.
Cancer Treatment Report 1986, 70, 1035-1036
 
Shiu W., Mok S.D., O.S., Tsao Y., Woo K., Li A., Leung N., Martin C.
Phase II trial of 4, epidoxorubicin in advanced gastrointestinal tumour.
Oncology 1986, 43, 341-343.
 
Shiu W., Schor S.
Quantitative study of migration of lymphocyte subsets through 3.D collagen gel.
Cell structure & Function 1986, 11, 227-233
 
Shiu W., Schor S., Chang j., Crowther D.
Migration of leukaemic lymphocytes through a 3.D collagen gel: a possible prognostic factor.
Scand J. of Haemato 1. 1987, 38, 17-122.
Ng C., Chick W., Tsao S.Y., Shiu W., Sung J., Lee J., Cheng P., Martin C.
Peripheral blood lymphocyte subsets in NPC.
Oncology, 1987, 44, 38-41.
 
Leung S.F., Taso Y., Shiu W.
Pretreatment necknode biopsy, distant metastases, and survival in Nasopharyngeal cancer.
Head & Neck 1993 July, 15(4), 296-299.
 
Shiu W., Schor S.
Quantitative study of various factors influencing the migration of lymphocytes in viro: glucocortico-steriod, PHA, cyclosporine A, and heparin.
Cell Biology Int. Reports 1987, 11, 171-180
 
Shiu W., Mok S., Leung N., Li M., Zacharia A., Martin C
Phase II study of high dose etoposide (VP16) in hepatocellular carcinoma.
Japanese J. of clin. Oncol. 1987, 17, 113-115.
 
Tugwood J., Lau W., O.S., Taso Y., Martin C., Shiu W., Desganes C., Jones P., Arrand J.
EBV specific transcription in normal and malignant nasopharyngeal biopsies in lymphocytes from healthy donor and infectious mononucleosis patients.
J. Gen. Virol. 1987, 68, 1081-1091.
 
Shiu W.
A clinical study of 8 cases of carcinoid tumor and a literature reviews.
British J of Clinical Practice 44(11)467-468, 1990.
 
Shiu W., Tsao S.
Etoposide in the treatment of advanced nasopharyngeal carcinoma.
European J. cancer & Clinical Oncology 24, 797-798, 1998.
 
Shiu W., Tsang V., Lam Y., Zacharia A., Martin C.
A randomized cross-over trial comparing low dose metoclopramide and chlorpromazine with high dose metoclopramide in Chinese patients with advance cancer receiving cisplatium and 5FU.
Cancer Chemotherapy Pharmcol. 20, 259-262, 1987.
 
Shiu W., Teo P., Wong K.
The efficacy of combination cisplatium, adriamycin, cyclophosphamide in malignant thymoma.
Bristish J. of Clinical Practice 44(11)519-520, 1990.
 
Teo P., Shiu W., Wu P., Tsao Y., Martin C.
Germinoma of the third centricle-complete response to radiation therapy documented.
Acta Oncologica 27,857-858, 1988.
 
Shiu W.
Efficacy of high dose epirubicin in hepatocellular.
Japanese J. of Clinical Oncology, 18, 235-237, 1988.
 
Teo P., Shiu W., Choi P.
Soft tissue sarcoma, the experience of a regional hospital in Hong Kong.
Clin Oncol (R coll Radio) Mar 1992, (2)83-88.
 
Li M., Shiu W., Li A.
The use of double valve Denver Peritoneal venous shunt for malignant ascitis.
Annals of the Academy of Medicine, Dingapore, 17:129-31, 1988.
 
Wallington M., Shiu W.
Hypertrophic Pulmonary osteoarthropathy and Nasopharyngeal Carcinoma in a young Chinese patient.
Australian Radiology, 32:444-447, 1988.
 
Cheung T., Wong W., Shiu W., Chang A.
A new combination chemotherapy for the treatment of Endodermal sinus tumor.
The Australian and New Zealand J of Obstetrics and Gynaecology 29, 346-349, 1989.
 
Ng C.S., Leung W., Shiu W., Cheng P., Feng C.S.
Diagnosis:Rhabdomyosarcoma Presenting in the bone marrow.
Pathology 21, 88-89, 1989.
 
Leung S.F., Tsao Y., Teo P., Choi P., Shiu W.
Ovarian ablation failure by radiation: a comparison of two dose Schedules.
British J. of Raiology June 1991, 64(762)537-538.
 
Leung W., Shiu W., Pang J.
Combination cyclophosphamide and Etoposide in Treatment of Small Cell Lung Cancer.
Medical Oncology and tumor Phamacotherapy 7(1), 31-34, 1990.
 
Cheng P., Shiu W., Leung T., Ho S., Wong K., Metreweli C.
A study of lymphocyte kinetics in nasopharyngeal carcinoma with Indium 111 oxine labeled lymphocytes.
Clinial Exp. Immunol., 74, 398-403, 1988.
 
Cheng P., Shiu W., Tsao Y. O., S.K.
Lymphopenia and deranged lymphocytes subsets in nasopharyngeal carcinoma.
Clinical Otolaryngol 13, 885-891, 1988.
 
Tsao S. Y., Shiu W.
Rdiotherapy and chemotherapy for nasopharyngeal carcinoma.
J. of Ear, Nose and Throat 69, 272-278, 1990.
 
Teo P., Shiu W., Tsao Y.
Clinical study of adenocarcinoma of unknown primary site in Hong Kong.
Singapore Medical Journal 130, 571-573, 1989.
 
Leung W., Shiu W., Chan M., Leung N., Li A., Metreweli C.
Treatment of inoperable hepatocelluar Carcinoma by intrahepatic arterial chemotherapy with lipoiol and 4 epidoxorubicin.
Regional Cancer Treatment, 2,145-148, 1989.
 
Shiu W., Dewar G., Leung N., Leung W., Chan M., Tao M., Lui C., Chan C., Lau W., Metrewelli C., Li A.
Hepatocellular carcinoma in Hong Kong:A clinical study on 340 cases.
Oncology 47, 241-245, 1990.
 
Teo P., Tsao Y., Shiu W., Leung W., Tsang V., Yu P., Lui C.
A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong.
International J of Radiation Oncology, Biology, Physics, 17, 515-530, 1989.
 
 
 
Teo P., Leung S.F., Yu P., Tsao S., Foo W., Shiu W.
A comparison of Ho’s, UICC and AJC stage classification for nasopharyngeal carcinoma.
Cancer Jan 15,1991, 67(2)434-439.
 
Teo P., Leung S.F., Yu P., Lee W.Y., Shiu W.
A retrospective comparison between different stage classification for NPC.
British J. of Radiology 63, 716-719, 1990.
 
Leung S.F., Tsao Y., Shiu W.
Treatment outcome of spinal cord compression by nasopharyngeal carcinoma.
British J. of Radiology 63, 716-719, 1990.
 
Leung S., Teo P., Shiu W., Tsao Y., Leung T.
Clinical features and management of distant metastases of NPC.
The J. of Otolamgology Feb 1991, 20(1)27-29
 
Leung N., Tam J., Leung T., Lau W.Y., Shiu W., Li A.
Does hepatitis C virus infection contribute to hepatocellular carcinoma.
Cancer July 1992, 70(1)40-44.
 
Shiu W., Tao M., Leung T.
Phase II study of combination vincristine, epirubicin, and cyclophosphamide in advanced breast cancer in Chinese patients.
European J. of cancer and clinical oncology 1991, 27(12)1710.
 
Leung W., Shiu W., Pang J.
Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable no-small cell lung cancer.
Oncology 1992, 49(5)321-326.
 
Shiu W., Teo P., Leung W.
Efficacy of oral sequential use of cyclophosphamide, methotrexate and 5FU in advanced beast cancer.
Indian J. of cancer chemotherapy, 10(2)125-128,1998.
 
 
 
Shiu W.
Assessment of quality of life in cancer patients.
Journal of the Hong Kong Association of occupational Therapists, 2(1), 33-35, 1986.
 
Wallington M., Shiu W., Martin C., Tsao Y., Teo P.
Lung cancer survival in Hong Kong.
Asean J. of clinical sciences, 9(3), 89-99, 1989.
 
Shiu W., Teo P.
Clinical features of soft tissue sarcoma in Hong Kong.
Asean J. of clinical sciences, 8(3), 45-48, 1986.
 
Martin C., Tsao Y. Shiu W., Cheng P., Teo P.
Teaching oncology in the undergraduate curriculum in Hong Kong.
Hong Kong College of General Pracititioners, 9(7), 2582-2585, 1987.
 
Wong K., Shiu W., Tsao Y.
Management of malignant pleural effusion.
Journal of the Hong Kong Physiotherapy Association, 7, 26-28, 1985.
 
Shiu W.
Tamoxifen induced cranial diabetes insipidus in metastatic cancer of the breast.
Asean J. of clinical sciences, 9(2)93-94, 1989.
 
Wallington M., Martin C., Tsao Y., Teo P., Shiu W.
Thyroid carcinoma in children and young adult in Hong Kong.
The Hong Kong J. of Paediatrics, 1, 32-37, 1988.
 
Shiu W., Martin C.
The management of breast cancer: a review.
J. of the Hong Kong Practitioner, 8(12)2187-2192, 1986.
 
Shiu W., Tsao Y., Leung T., Mok S., Li A., Chan M., Stewart I., Metreweli C.
An update on hepatocellulat carcinoma.
J. of the Hong Kong Practitioner, 10(11), 3516-3519, 1988.
 
 
 
Shiu W., Leung T.
A survey on new anticancer drugs.
J. of the Hong Kong Practitioner,10(11), 3516-3519, 1988,
 
Shiu W.
Value of microcomputer in clinical research.
United Bulletin, 39-41, 1984.
Chinese University Press.
 
Shiu W.
Recombinant human gamma interferon in primary hepatocellular carcinoma.
J. of the Royal Society of Medicine, 79, 185, 1986.
 
Shiu W., Leung T.
Alpha 2B interferon in Chinese patients: A tolerability study.
Clinical Trials of Journal, 24(4)269-274, 1987.
 
Choi P. Teo P. Foo W. Leung S. Tsao Y. Shiu W.
High dose rate remote afterloading irradiation of carcinoma of the cervix in Hong Kong:unexpected high complication rate.
Clini.Oncology (R.Coll.Radiol)1992May4(3)186-191
 
Shiu W. Leung T. Tao M.
A clinical study of PSP (polysaccharide peptide) on the activity of the peripheral blood counts during chemotherapy.
Phytotherapy research 6,217-218,1992
 
Teo P. Shiu W. Leung S. Lee W.
Prognostic factors in NPC investigated by computer tomography-an analysis of 659 patients.
Radiortherapy and Oncology 1992Feb23(2)79-93
 
Lee K. Chan K. Leung W. Chan M. Lau W. Shiu W.
Disposition of epribicin in an oily contrast medium after intravenous and intrahepatic arterial administration in liver cancer-a preliminary report.
European J.Drug Meta.Pharmacokinetic 1992July17(3)221-226
 
 
Shiu W.
Primary liver cancer in Hong Kong
Cancer Chemotherapy Pharmacol 1992,31Suppl.143-145
 
 
Leung W.T. Shiu W. Leung N. Chan M. Tao M. Li A. Metrewelli C.
Treatment of inoperable hepatocellular carcinoma by intra-arterial lipoidol and epirubicin .
Cancer Chemtherapy and Pharmacology 1992 29(5)401-404
 
Dugan M. Choy D. Ngai A. Sham J. Choi P. Shiu W.Leung T. Teo P. Prased U. Lee A.
Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal cancer in South-East Asia-Asian Oceanian Clinical Oncology Association Group Study.
J. Clin.Oncolo 1993 Jan11(1)70-76
 
Shiu W.
Current cancer treatment in Hong Kong
Gan To Kagaka Ryoho (Japan) July 1992,19(8suppl)1134-1135
 
Lin J. Shiu W. Leung W. Ho S. Tao M.
Phase II study of high dose ifosfamide in hepatocellular carcinoma.
Cancer Chemotherapy Pharmacol 1993,31(4)338-339
 
Shiu W.Leung S. Leung W.
Expression of B2 microglobulin by nasopharyngeal cancer
British J. of Cancer Sept 1992,66(3)555-557
 
Shiu W. Wong F. Martin C.
Oncology Day Ward:an evaluation.
Singapore Med.J.April198728(2)190-191
 
Leung S.,Chan-Ho,Shiu W.
A cancer attitude survey among medical undergraduate in Hong Kong.
J.cancer education (US)Summer1994,73-76
 
 
 
Lau W. Arnold M. Leung N. Leung T. Chan M. Shiu W.
Hepatic intra-arterial lipoidol ultrasound guided biopsy in the management of hepatocellular carcinoma.
Surg.Oncol.1993,2(2)119-124
 
 
 
Shiu W.
Treatment of extravasation of anticancer drugs
Hsiang Kang Hu Li Tsa Chih 1986Nov(41)72-73
 
Shiu W. Wong K.Tsao Y.Pang J
The management of lung cancer:A Review
Journal of the Hong Kong Medical Association 38,(4)163-165,1986
 
Shiu W.
Breast cancer: an overview of current treatment
Medical Progress July,21-26,1991

 
 
Abstract and Proceedings
 
Cheng P., Shiu W., Leung J., Ho S., Wong K.
Kinetics of lymphocyte migration in NPC.
Abstract in EORTC(H.K.Sym.)20,1987.
 
Edmundson J., Steward W., Shiu W.
Pharmacokinetics of etoposide in patients with small cell lung cancer.
British J. of cancer 1984,48,114.
 
Shiu W., Schor S.
Migration of human T and B lymphocytes in 3D collagen matrices.
British J. of cancer1984,49,397.
 
Shiu W., Leung W.T., Pang J., Wong K.
Phase II study of combination cyclophosphamide and VP16-213 in small cell lung cancer.
Abstract in EORTC(H.K.Sym.)24,1987.
 
Shiu W., Martin C., Mok S.D., Li M., Li A.
Efficacy of VP16-213 in hepatocellular carcinoma.
Abstract in Cancer Treatment ,Beijing Int.Sym.52,1986.
 
Martin C., Shiu W., Tsaos. Y., O.K.O., Leung S.F.
Adjuvant chemotherapy(C/T) for NPC.
Abstract in Cancer Treatment, Beijing Int.Sym.53,1986
 
Woo K.S., Tse L.K., Pun C., Shiu W., Martin C.
Evaluation of cardiotoxicity of 4, epidoxorubicin.
Abstract in Asean congress of Cardiology, Indonesia, June 1986.
 
Tsao S.Y., Shiu W., Ho S.
Combined CA50 and CA153 IRMA for monitoring distant metastases in breast cancer.
Australian Bicentenary Breast Cancer Conference, Nov.1988,Australia.
 
 
 
Tsao S.Y., Shiu W., Leung W.T., Tsao Y.
Place of neoadjuvant chemotherapy in radiotherapy of advanced Nasopharyngeal carcinoma.
2nd International conference in head and neck cancer, Boston, 1988.
 
Shiu W., Pang J., Wong K., Tsao S.Y., Martin C., Lam Y.
A randomized control study of intensive treatment in non-small cell lung cancer (limited stage).
Hong Kong .Canton, Macau Chest Meeting 1986.
 
Shiu W., Li M., Leung N., Chan M., Leung W.T.
Non-surgical treatment for inoperable hepatocellular carcinoma in Hong Kong.
Symp. on Recent Advances in Liver Cancer,14 Oct, 1988, Hong Kong.
 
Leung W.T., Shiu W., Tsao Y., Pang J., Law J., Tao M., Teo P., Leung S.F.
Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable limited stage non-small cell lung cancer.
Abstract in ASCO, May 1990.
 
Natkunam A., Tsang V., Shiu W., Martin C., Jones G.
Effects of cisplatinum in treatment on renal and electrolyte disturbance.
Abstract in International Conference on Chemical Pathology, Hong Kong, 30 Aug 1998.
 
Leung W.T., Shiu W., Tsao Y., Tao M., Teo P., Leung S.F.
Phase II study of carboplatin and 5FU combination chemotherapy in treatment of advanced Nasopharyngeal Carcinoma.
Abstract in second Novantrone Investigator Meeting, Bangkok, April 1990.
 
Choi P., Teo P., Foo W., Leung S.F., Tsao.Y., Shiu W.
High dose rate remote after loading irradiation of carcinoma of cervix in Hong Kong: unexpected high complication rate.
British society of Radiology Meeting, Edinburgh 1990.
 
 
 
Lau C., Chan K., Ho S., Shiu W.
Use of lipiodol for selective drug targeting to tumor: Preliminary Results of pharmacokinetic study.
Abstracts in Hong Kong Pharmacological society Meeting, Oct 1998.
Shiu W., Teo P., Wong F., Chang A.
Efficiency of combination cisplatinum vinblastine and VP16-213 in Ovarian yolk sac tumour.
Abstract in 15th International congress of Chemotherapy 1998.
 
Leung T., Shiu W., Yeung A., Ho S., Tao M.
Tolerability study of adoptive immunotherapy using low dose cyclophosphamide and interleukin 2 with lymphokine activated killer cells in 2 Chinese patients.
Abstract in The Hernonetic 14th International Apheresis Symposium, April 1989.
 
Leung T., Shiu W., Tao M., Teo P., Leung S.F. Choi P.
Phase II study of Carboplatin and FU combination chemotherapy in treatment of advanced NPC.
Abstract in ASCO(American Society of Clinical Oncology)1991.
 
Cheng P., Leung W., Shiu W.
Etoposide high dose Ara-C and asparaginase in poor risk acute myeloid leukaemia in Hong Kong.
Abstract in EORTC (HK Sym)14 1987.
 
Steward W., Thatcher N., Edmundson J., Shiu W., Wagstaff J., Crowther D.
VP16 infusion for the treatment of metastatic lung cancer.
British J. of Cancer 48,117-118,1984.
 
Leung N., Shiu W., Mok S., Tsao Y., Ho S., Cheung C.
Evaluation of serum tumor marker in hepatocellular carcinoma among Hong Kong Chinese
Abstract in EORTC (HKSym) 19,1987.
 
Shiu W., Tsa O., Teo P., Leung W., Marin C., Choy D., Choi P.
Efficacy of cisplatium as a single agent in nasopharyngeal cancer.
Abstract in EORTC (HKSym) 19, 1987.
 
 
Leung N.Chan M.Li M. Leung T.Shiu W.
Intra-arterial lipoidol epirubicin chemotherapy for inoperable liver cancer.
Abstract in liver cancer symposium,Bangkok,Feb 1988
 
 
Cheng P. Shiu W. Tsao Y. O.S.K. Martin C.
Lymphopenia and deranged lymphocyte subsets in pre-treatment NPC.
Abstract in EORTC (HK Sym)19,1987
 
 
 
 
Books
 
Chinese version of UICC manual of adult and paediatric Medical Oncology.
Translated by Sun Yan and Shiu
 
Symposium on recent advance in liver cancer.
Chapter on non-surgical treatment of inoperable hepatocellular carcinoma in Hong Kong
Editors:Chew E. Shiu W.
 
Recent advance in cancer 1989
Editors:Chew E. Shiu W.
The Chinese University of Hong Kong 1989
 
Nasopharyngeal carcinoma
Chapter on chemotherapy in NPC 213-220
The Chinese University Press  1991
Editor:Van Hasselt & Gibb